-
Sigma records 41% EBIT growth in FY25
Wednesday | Aug 27 2025SIGMA recorded normalised EBIT growth of 41% and statutory net profit after tax of $529.9 million in its first post-merger end-of-year results, according to an ASX statement this morning.
-
Painkiller link with AMR
Wednesday | Aug 27 2025IN THE first study of its kind, Australian researchers have discovered that ibuprofen and paracetamol could be driving antimicrobial resistance (AMR) when used in conjunction with broad-spectrum antibiotic ciprofloxacin.
-
Presolol 100 SSSI
Wednesday | Aug 27 2025THE Therapeutic Goods Administration (TGA) has been advised by Alphapharm that its Presolol 100 (labetalol hydrochloride 100mg) tablets, used to treat hypertension, are in shortage until 03 Oct 2025 due to manufacturing issues.
-
Call for expanded vaccination access
Wednesday | Aug 27 2025GENERAL practitioners are calling on the New South Wales Government to urgently expand free vaccination access state-wide, including an upcoming intranasal influenza vaccine for young children.
-
Allergy rates rise
Wednesday | Aug 27 2025MORE than eight million Australians (30%) now live with allergic disease, up from 4.1 million (19.6%) in 2007, according to a new Deloitte Access Economics report.
-
Crampeze: effective multi-combination solution vs magnesium alone for cramp relief
Wednesday | Aug 27 2025CRAMPEZE combines Viburnum Opulus (cramp bark), magnesium and a unique combination of ingredients. It is an effective multi-combination product versus magnesium alone for cramp relief.
-
Revive Tears – PBS-listed
Wednesday | Aug 27 2025REVIVE Tears lubricating eye drops provide long-lasting and soothing relief against burning, irritation and discomfort due to dry eye.
-
PD for Wed 27 Aug 2025
Wednesday | Aug 27 2025Sigma records 41% EBIT growth for FY25, painkiller link with AMR, new allergy report reveals rising rates and costs, and more
-
PD breaking news – Sigma records 41% EBIT growth in FY25 results
Wednesday | Aug 27 2025Sigma recorded normalised EBIT growth of 41% in its first post-merger end-of-year results. Key figures include…
-
APC public consultation EOI
Tuesday | Aug 26 2025THE Australian Pharmacy Council (APC) has announced that the expression of interest (EOI) to participate in the public consultation forums for the Pharmacist Capability Framework is now open.
PARTNER SITES
to top